Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar 4;15(1):13-19.
doi: 10.1007/s12308-021-00478-0. eCollection 2022 Mar.

Intracerebral manifestation of iatrogenic, immunodeficiency-associated polymorphic B-LPD with morphology mimicking Hodgkin lymphoma: a case report and literature review

Affiliations
Case Reports

Intracerebral manifestation of iatrogenic, immunodeficiency-associated polymorphic B-LPD with morphology mimicking Hodgkin lymphoma: a case report and literature review

Leonie Saft et al. J Hematop. .

Abstract

Iatrogenic immunodeficiency-associated lymphoproliferative disorders (IA-LPD) may arise in patients treated with immunosuppressive drugs for autoimmune disease or other conditions. Polymorphic EBV-positive B-lymphoproliferations often have features mimicking Hodgkin lymphoma and typically a self-limited, indolent course. We present an unusual case with isolated, intracerebral manifestation of polymorphic B-LPD with features of classic Hodgkin-lymphoma in an immunosuppressed patient treated with methotrexate and infliximab, including clinical-radiological features and a detailed description of morphological findings, together with a literature review on reported cases of primary CNS manifestation of cHL and IA-LPD with Hodgkin-like morphology. The patient achieved complete remission following neurosurgery with gross total tumor resection and drug withdrawal without any additional treatment. Post-operative staging revealed no evidence for focal relapse or systemic disease during the 18 months follow-up period. Among the previously reported 24 cases of primary, isolated Hodgkin lymphoma in the central nervous system, three similar cases of iatrogenic, IA-LPDs were identified and are discussed here. Polymorphic B-LPD are destructive lesions with a range of morphologic features and disease manifestations. It is clinically important to recognize the spectrum of proliferations with features of classic Hodgkin lymphoma in immunodeficiency, iatrogenic settings, because they are likely to impact the choice of treatment strategies.

Supplementary information: The online version contains supplementary material available at 10.1007/s12308-021-00478-0.

Keywords: CNS; EBV; Hodgkin-like cells; Iatrogenic; Lymphoproliferative disorder; Polymorphic B-LPD.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare no competing interests.

Figures

Figure 1.
Figure 1.
T1-weighted magnetic resonance image shows a left-sided, well-circumscribed contrast-enhancing lesion measuring 2 cm in diameter (a). T2-weighted FLAIR image (fluid attenuated inversion recovery) reveals marked surrounding edema (b)
Figure 2.
Figure 2.
Histological examination demonstrates a well-demarcated, intracerebral polymorphic infiltrate with small lymphocytes, numerous plasma cells, eosinophilic granulocytes, and scattered large cells with Hodgkin/Reed-Sternberg morphology (a,b). The atypical cells stain positive for CD30 (c), negative for CD15 (d) and CD20 (e), CD79a weakly positive (f), and positive for both LMP-1 (g) and EBER/EBV (h)

Similar articles

References

    1. Swerdlow SH (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon
    1. Kamel OW, van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, Montgomery PG, Warnke RA, Dorfman RF. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993;328(18):1317–1321. doi: 10.1056/NEJM199305063281806. - DOI - PubMed
    1. Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, Schultz M, Murren J. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14(6):1943–1949. doi: 10.1200/JCO.1996.14.6.1943. - DOI - PubMed
    1. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002;46(12):3151–3158. doi: 10.1002/art.10679. - DOI - PubMed
    1. Loo EY, Medeiros LJ, Aladily TN, Hoehn D, Kanagal-Shamanna R, Young KH, Lin P, Bueso-Ramos CE, Manning JT, Jr, Patel K, Thomazy V, Brynes RK, Goswami M, Fayad LE, Miranda RN. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. Am J Surg Pathol. 2013;37(8):1290–1297. doi: 10.1097/PAS.0b013e31828e6564. - DOI - PubMed

Publication types